(Q35536519)

8 August 2017

In vitro evaluation of tigemonam, a novel oral monobactam (English)

1 reference

8 August 2017

Tanaka SK

1

1 reference

8 August 2017

Summerill RA

2

1 reference

8 August 2017

Minassian BF

3

1 reference

8 August 2017

Bush K

4

1 reference

8 August 2017

Visnic DA

5

1 reference

8 August 2017

Bonner DP

6

1 reference

8 August 2017

Sykes RB

7

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 February 1987

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

1 reference

8 August 2017

31

1 reference

8 August 2017

219-225

1 reference

8 August 2017

2

1 reference

Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

The emergence of bacterial resistance and its influence on empiric therapy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

A follow-up survey of transferable, plasmid-encoded trimethoprim resistance in a general hospital (1975-1983).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

Current needs in chemotherapy for bacterial and fungal infections.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

In vivo evaluation of tigemonam, a novel oral monobactam

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

Impact of bacterial resistance to antibiotics on therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174695

Antibiotic sensitivities of urinary pathogens, 1971-82

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3105448

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.31.2.219

1 reference

8 August 2017

1 reference

8 August 2017

1 reference